<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mrj</journal-id><journal-title-group><journal-title xml:lang="ru">Современная ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Modern Rheumatology Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1996-7012</issn><issn pub-type="epub">2310-158X</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1996-7012-2012-722</article-id><article-id custom-type="elpub" pub-id-type="custom">mrj-407</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Рациональное применение антибиотиков в ревматологии</article-title><trans-title-group xml:lang="en"><trans-title>Ananyeva Rational antibiotic use in rheumatology</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белов</surname><given-names>Б. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Belov</surname><given-names>Boris Sergeyevich</given-names></name></name-alternatives><email xlink:type="simple">belovbor@yandex.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шубин</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shubin</surname><given-names>S V</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ананьева</surname><given-names>Л. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Ananyeva</surname><given-names>L P</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>12</day><month>06</month><year>2012</year></pub-date><volume>6</volume><issue>2</issue><issue-title>№2 (2012)</issue-title><fpage>7</fpage><lpage>16</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Белов Б.С., Шубин С.В., Ананьева Л.П., 2012</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="ru">Белов Б.С., Шубин С.В., Ананьева Л.П.</copyright-holder><copyright-holder xml:lang="en">Belov B.S., Shubin S.V., Ananyeva L.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://mrj.ima-press.net/mrj/article/view/407">https://mrj.ima-press.net/mrj/article/view/407</self-uri><abstract><p>В современных условиях борьба с инфекциями и инфекционными осложнениями представляет собой одну из наиболее актуальных проблем медицины. При этом важное место отводится рациональной терапии антиинфекционными препаратами. В ревматологии необходимость применения антибиотиков связана по меньшей мере с двумя факторами: эрадикацией возбудителя-триггера (инфекционного агента, запускающего иммунопатологические механизмы воспаления) и лечением коморбидной инфекции. Представлены сведения об этиологических агентах, подробные схемы антимикробной терапии при основных инфекциях, наблюдаемых в современной ревматологии.</p></abstract><trans-abstract xml:lang="en"><p>To control infections and infectious complications is one of the most urgent challenges in medicine under present-day conditions. At the same time, rational therapy with anti-infective drugs occupies a highly importance place. In rheumatology, the necessity of using antibiotics is associated with at least two factors, such as eradication of a pathogen trigger (an infectious agent that triggers the immunopathological mechanisms of inflammation) and treatment of comorbid infection. The paper gives information on etiological agents and detailed antimicrobial therapy regimens for the major infections observed in modern rheumatology.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>А-стрептококковый тонзиллит</kwd><kwd>реактивный артрит</kwd><kwd>боррелиоз Лайма</kwd><kwd>септический артрит</kwd><kwd>болезнь Уиппла</kwd><kwd>антибиотики</kwd></kwd-group><kwd-group xml:lang="en"><kwd>group A streptococcal tonsillitis</kwd><kwd>reactive arthritis</kwd><kwd>Lyme borreliosis</kwd><kwd>septic arthritis</kwd><kwd>Whipple 's disease</kwd><kwd>antibiotics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">&lt;div&gt;&lt;p&gt;Насонова В.А., Белов Б.С., Страчунский Л.С. и др. Антибактериальная терапия стрептококкового тонзиллита (ангины) и фарингита. Рос. ревматол. 1999; 4; 20—7.&lt;/p&gt;&lt;p&gt;Насонов Е.Л., Ананьева Л.П., Белов Б.С. и др. Рациональное применение антибиотиков в ревматологии. Методические рекомендации № 8. М., 2008; 24 с.&lt;/p&gt;&lt;p&gt;Wormser G.P., Dattwyler R.J., Shapiro E.D. et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43(9):1089—134.&lt;/p&gt;&lt;p&gt;Rao N. Septic arthritis. Curr Treat Opt Infect Dis 2002; 4: 279—87.&lt;/p&gt;&lt;p&gt;Trampuz A., Steckelberg J.M. Septic arthritis. Curr Treat Opt Infect Dis 2003; 5: 337—44.&lt;/p&gt;&lt;p&gt;Antibiotic prophylaxis for dental patients with total joint replacements. JADA 2003; 134: 895—8.&lt;/p&gt;&lt;p&gt;Antibiotic prophylaxis for urological patients with total joint replacements. J Urology 2003; 169(5): 1796—7.&lt;/p&gt;&lt;p&gt;Feurle G.E., Junga N.S., Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Gastroenterology 2010; 138(2): 478—86.&lt;/p&gt;&lt;p&gt;Desnues B., Al Moussawi K., Fenollar F. New insights into Whipple's disease and Tropheryma whipplei infections. Microbes Infect 2010; 12(14—15): 1102—10.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation><mixed-citation xml:lang="en">&lt;div&gt;&lt;p&gt;Насонова В.А., Белов Б.С., Страчунский Л.С. и др. Антибактериальная терапия стрептококкового тонзиллита (ангины) и фарингита. Рос. ревматол. 1999; 4; 20—7.&lt;/p&gt;&lt;p&gt;Насонов Е.Л., Ананьева Л.П., Белов Б.С. и др. Рациональное применение антибиотиков в ревматологии. Методические рекомендации № 8. М., 2008; 24 с.&lt;/p&gt;&lt;p&gt;Wormser G.P., Dattwyler R.J., Shapiro E.D. et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43(9):1089—134.&lt;/p&gt;&lt;p&gt;Rao N. Septic arthritis. Curr Treat Opt Infect Dis 2002; 4: 279—87.&lt;/p&gt;&lt;p&gt;Trampuz A., Steckelberg J.M. Septic arthritis. Curr Treat Opt Infect Dis 2003; 5: 337—44.&lt;/p&gt;&lt;p&gt;Antibiotic prophylaxis for dental patients with total joint replacements. JADA 2003; 134: 895—8.&lt;/p&gt;&lt;p&gt;Antibiotic prophylaxis for urological patients with total joint replacements. J Urology 2003; 169(5): 1796—7.&lt;/p&gt;&lt;p&gt;Feurle G.E., Junga N.S., Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Gastroenterology 2010; 138(2): 478—86.&lt;/p&gt;&lt;p&gt;Desnues B., Al Moussawi K., Fenollar F. New insights into Whipple's disease and Tropheryma whipplei infections. Microbes Infect 2010; 12(14—15): 1102—10.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
